DARK FOREST CAPITAL MANAGEMENT LP

Position in INCY — Incyte Corp

CIK 1853322 NEW YORK, NY

Position in INCY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,231,842

+$3,534,884 QoQ

Shares Held

37,331

+404.1% QoQ

Ownership

0.019%

of shares outstanding

% of Portfolio

0.28%

of 13F equity value

Holder Rank

#249

of 849 holders

Holding Since

Sep 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

DARK FOREST CAPITAL MANAGEMENT LP holds $39,189,502 across 23 Biotechnology names. INCY ranks #2 (10.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	134,982	$7,568,440
2	INCY	Incyte Corp This page	37,331	$4,231,842
3	SMMT	Summit Therapeutics Inc.	243,607	$3,549,353
4	CYTK	Cytokinetics Inc	36,708	$3,127,154
5	CORT	Corcept Therapeutics Inc	28,982	$2,519,984
6	SRRK	Scholar Rock Holding Corp	38,420	$2,113,100
7	IBRX	ImmunityBio, Inc.	209,163	$1,831,222
8	REGN	Regeneron Pharmaceuticals, Inc.	2,547	$1,588,156

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,231,842	37,331	+404.1%	Shares	Sole	2026-08-14
2026-03-31	$696,958	7,405	-17.1%	Shares	Sole	2026-05-15
2025-12-31	$881,818	8,928	+4.4%	Shares	Sole	2026-02-17
2025-06-30	$582,391	8,552	+11.3%	Shares	Sole	2025-08-14
2025-03-31	$465,084	7,681	+28.1%	Shares	Sole	2025-05-15
2024-12-31	$414,281	5,998	+23.3%	Shares	Sole	2025-02-14
2024-09-30	$321,642	4,866	-74.7%	Shares	Sole	2024-11-14
2023-09-30	$1,109,992	19,214	+1041.0%	Shares	Sole	2023-11-13
2022-03-31	$133,743	1,684	-15.0%	Shares	Sole	2022-05-13
2021-12-31	$145,405	1,981	+313.6%	Shares	Sole	2022-02-11
2021-09-30	$32,945	479	—	Shares	Sole	2021-11-16
No filing history on record for this holder in this stock.